[go: up one dir, main page]

ES2373901A1 - Energizing composition and dietetic supplement that contains it. (Machine-translation by Google Translate, not legally binding) - Google Patents

Energizing composition and dietetic supplement that contains it. (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2373901A1
ES2373901A1 ES201031194A ES201031194A ES2373901A1 ES 2373901 A1 ES2373901 A1 ES 2373901A1 ES 201031194 A ES201031194 A ES 201031194A ES 201031194 A ES201031194 A ES 201031194A ES 2373901 A1 ES2373901 A1 ES 2373901A1
Authority
ES
Spain
Prior art keywords
vitamin
supplement
composition
caffeine
asparagine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201031194A
Other languages
Spanish (es)
Other versions
ES2373901B1 (en
Inventor
Sergio Martínez Escobar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spheric Nanohealth S L
SPHERIC NANOHEALTH SL
Original Assignee
Spheric Nanohealth S L
SPHERIC NANOHEALTH SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spheric Nanohealth S L, SPHERIC NANOHEALTH SL filed Critical Spheric Nanohealth S L
Priority to ES201031194A priority Critical patent/ES2373901B1/en
Publication of ES2373901A1 publication Critical patent/ES2373901A1/en
Application granted granted Critical
Publication of ES2373901B1 publication Critical patent/ES2373901B1/en
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L1/3002
    • A23L1/302
    • A23L1/3051
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Energizing composition and dietary supplement that contains it. The present invention describes a new energizing and revitalizing composition comprising: 1.82% -59.76% vitamin c; 0.34% -40.87% thiamine hydrochloride; 0.34% -40.87% pyridoxine hydrochloride; 1.89% -51.00 of N-acetyl-l-cysteine; 3.82% -61.41% l-asparagine; 0.21% -30.34% vitamin e; 0.38% -43.54% l-glutamic acid; and 0.32% -11.73% caffeine. The composition is useful for the preparation of a dietary or nutritional supplement such as a beverage. The food supplement obtained has antioxidant properties and hepato-, neuro- and nephroprotective effects. (Machine-translation by Google Translate, not legally binding)

Description

Composición energizante y suplemento dietético que la contiene.Energizing composition and dietary supplement that contains it.

Campo de la invenciónField of the Invention

La presente invención se encuadra dentro del campo de los productos energizantes y revitalizantes destinados al consumo humano en general, y más en particular en situaciones de alto rendimiento físico y/o mental.The present invention fits within the field of energizing and revitalizing products intended for human consumption in general, and more particularly in situations of high physical and / or mental performance.

       \vskip1.000000\baselineskip\ vskip1.000000
    
Antecedentes de la invenciónBackground of the invention

Se conocen en el estado de la técnica diversas composiciones energéticas y revitalizantes, particularmente en forma de bebidas. Entre las numerosas bebidas que existen en el mercado cabe mencionar por ejemplo la bebida Red Bull ®.Various are known in the state of the art energetic and revitalizing compositions, particularly in form of drinks. Among the many drinks that exist in the market It is worth mentioning, for example, the Red Bull ® drink.

La composición de este producto contiene: agua, sacarina y azúcares, tales como glucosa; glucuronolactona, que consiste en un derivado de la glucosa que forma parte del tejido conectivo; estimulantes, como la taurina, un aminoácido; cafeína, en una cantidad de 32 mg/100 cc equivalente a una taza de café expresso; y vitaminas del grupo B, como la niacina (vitamina B3), el ácido pantoténico (vitamina B5), y las vitaminas B6 y B12.The composition of this product contains: water, saccharin and sugars, such as glucose; glucuronolactone, which it consists of a derivative of glucose that is part of the tissue connective; stimulants, such as taurine, an amino acid; Caffeine in an amount of 32 mg / 100 cc equivalent to one cup of coffee expresso and vitamins of group B, such as niacin (vitamin B3), the pantothenic acid (vitamin B5), and vitamins B6 and B12.

Estos componentes se caracterizan por sus distintas funcionalidades. Así, los sustratos hidrocarbonados aportan energía; los estimulantes son psicoestimulantes y aceleradores del metabolismo; y las vitaminas del grupo B están todas ellas relacionadas con el metabolismo de forma que optimizan el aumento de la velocidad metabólica de forma muy general.These components are characterized by their Different functionalities Thus, hydrocarbon substrates they provide energy; the stimulants are psychostimulants and metabolism accelerators; and the vitamins of group B are all of them related to metabolism so that they optimize the increase in metabolic speed in a very general way.

Según los propios fabricantes de estas bebidas, éstas presentan un efecto revitalizador y desintoxicante así como propiedades que incrementan las capacidades físicas y potencian la velocidad mental. Se trata por lo tanto de bebidas funcionales, no para quitar la sed, que han sido pensadas para su consumo en momentos de alta exigencia física y mental; como por ejemplo durante la conducción en autopistas muy largas que pueden inducir al sueño, en días de mucho trabajo, antes de practicar una actividad de mucho desgaste físico o antes de un examen.According to the manufacturers of these drinks, these have a revitalizing and detoxifying effect as well as properties that increase physical capabilities and enhance the mental speed It is therefore functional drinks, not to remove thirst, which have been designed for consumption in moments of high physical and mental demand; such as during driving on very long highways that can induce sleep, on a lot of work days, before practicing a lot of activity physical wear or before an exam.

Sin embargo este tipo de bebidas energizantes en general presentan una importante desventaja y es que producen un aumento del metabolismo, que conlleva de forma inexorable a un aumento de la producción de radicales libres y por lo tanto a un desequilibrio en el metabolismo oxidativo.However this type of energy drinks in In general, they have a significant disadvantage and they produce a increased metabolism, which inexorably leads to increased production of free radicals and therefore at a imbalance in oxidative metabolism.

En este sentido sigue existiendo la necesidad en el estado de la técnica de proporcionar una composición alternativa que cumpla satisfactoriamente con las propiedades deseables de este tipo de composiciones energizantes y revitalizadoras sin la desventaja asociada mencionada.In this sense the need still exists in the state of the art of providing an alternative composition that satisfactorily meets the desirable properties of this type of energizing and revitalizing compositions without the Associated disadvantage mentioned.

       \vskip1.000000\baselineskip\ vskip1.000000
    
Descripción de la invenciónDescription of the invention

La presente invención se refiere en un aspecto a una nueva composición que comprende:The present invention relates in one aspect to a new composition that includes:

1,82%-59,76% de vitamina C;1.82% -59.76% of vitamin C;

0,34%-40,87% de clorhidrato de tiamina;0.34% -40.87% of thiamine hydrochloride;

0,34%-40,87% de clorhidrato de piridoxina;0.34% -40.87% of pyridoxine hydrochloride;

1,89%-51,00 de N-acetil-L-cisteína;1.89% -51.00 of N-acetyl-L-cysteine;

3,82%-61,41% de L-asparagina;3.82% -61.41% of L-asparagine;

0,21%-30,34% de vitamina E;0.21% -30.34% of Vitamin E;

0,38%-43,54% de ácido L-glutámico; y0.38% -43.54% of L-glutamic acid; Y

0,32%-11,73% de cafeína.0.32% -11.73% of caffeine.

       \vskip1.000000\baselineskip\ vskip1.000000
    

Los componentes que se utilizan para la preparación de la composición de la invención pueden encontrarse en forma neutra o de sales derivadas farmacéuticamente aceptables. La vitamina E puede ser en principio cualquiera de las 8 formas llamadas tocoferoles o trocotrienoles, preferentemente \alpha-tocoferol. La composición de la invención se prepara de forma sencilla mediante un procedimiento que comprende la mezcla de los ingredientes.The components that are used for the Preparation of the composition of the invention can be found in neutral form or pharmaceutically acceptable derivative salts. The Vitamin E can be in principle any of the 8 ways called tocopherols or trocotrienols, preferably α-tocopherol. The composition of the invention. It is prepared in a simple way by a procedure that includes The mixture of the ingredients.

       \newpage\ newpage
    

       \global\parskip0.930000\baselineskip\ global \ parskip0.930000 \ baselineskip
    

En una realización particular la composición comprende:In a particular embodiment the composition understands:

15,65% de vitamina C;15.65% of vitamin C;

9,39% de clorhidrato de tiamina;9.39% of thiamine hydrochloride;

9,39% de clorhidrato de piridoxina;9.39% of pyridoxine hydrochloride;

18,79% de N-acetil-L-cisteína;18.79% of N-acetyl-L-cysteine;

21,29% de L-asparagina;21.29% of L-asparagine;

4,17% de vitamina E;4.17% of Vitamin E;

18,79% de ácido L-glutámico; y18.79% acid L-glutamic; Y

2,50% de cafeína.2.50% of caffeine.

       \vskip1.000000\baselineskip\ vskip1.000000
    

Esta composición, en adelante composición de la invención, aporta sustratos biológicos que optimizan rutas metabólicas importantes en el metabolismo energético, todo ello mediado por la mejora del balance redox, favoreciendo un ambiente reductor en el citoplasma celular.This composition, hereinafter the composition of the invention, provides biological substrates that optimize routes important metabolic in energy metabolism, all mediated by the improvement of the redox balance, favoring an environment reducer in the cell cytoplasm.

Una ventaja de la composición de la invención reside en que su efecto estimulante, con el uso de aceleradores metabólicos del grupo de la vitamina del grupo B (vitamina B1 y vitamina B6) junto con la cafeína y los aminoácidos, como la asparagina y el ácido L-glutámico, se encuentra balanceado con una potentísima composición antioxidantes a base de N-acetil-Cisteína, vitamina C y vitamina E.An advantage of the composition of the invention resides in that its stimulating effect, with the use of accelerators metabolic of group B vitamin group (vitamin B1 and vitamin B6) along with caffeine and amino acids, such as asparagine and L-glutamic acid, is found balanced with a very powerful antioxidant composition based on N-acetyl-Cysteine, vitamin C and Vitamin E.

En comparación de otras composiciones energizantes del estado de la técnica consideradas estimulantes y aceleradores metabólicos, la composición de la presente invención consiste en un balanceador metabólico en situaciones de alto rendimiento. En este sentido la composición antioxidante le confiere a la composición de la invención propiedades que son extremadamente beneficiosas en situaciones de estrés metabólico tanto físico como psíquico, como son su capacidad de protección de órganos especialmente sensibles al desequilibrio oxidativo (sistema nervioso central, hígado, riñones), aunque es evidente que su capacidad de actuación a nivel de órganos y aparatos es sistémica, es decir, generalizada en toda la economía.In comparison to other compositions state of the art energizers considered stimulants and metabolic accelerators, the composition of the present invention consists of a metabolic balancer in high situations performance. In this sense the antioxidant composition gives it to the composition of the invention properties that are extremely beneficial in situations of metabolic stress both physical and psychic, as are their ability to protect organs especially sensitive to oxidative imbalance (nervous system central, liver, kidneys), although it is clear that their ability to performance at the level of organs and devices is systemic, that is, widespread throughout the economy.

Por tanto en otro aspecto la composición se relaciona con su empleo en la elaboración de un suplemento dietético o composición alimenticia energetizante o revitalizante con capacidad antioxidante, neuroprotectora, hepatoprotectora y nefroprotectora así como antienvejecimiento.Therefore in another aspect the composition is relates to its use in the preparation of a dietary supplement or energizing or revitalizing food composition with antioxidant, neuroprotective, hepatoprotective and Nephroprotective as well as anti-aging.

En un aspecto adicional la invención se refiere a un suplemento dietético o composición alimenticia que comprende la composición de la invención. Dicho suplemento dietético o composición alimenticia, en adelante suplemento de la invención, comprende una cantidad de la composición de la invención y un excipiente o vehículo farmacéuticamente aceptable combinable con dicha composición que no presenta ningún efecto adverso sobre el organismo tratado. El suplemento de la invención puede comprender excipientes tales como fructosa, agua, aromas, colorantes, etc.In a further aspect the invention relates to a dietary supplement or food composition comprising the composition of the invention Said dietary supplement or food composition, hereinafter supplement of the invention, it comprises a quantity of the composition of the invention and a pharmaceutically acceptable excipient or vehicle combinable with said composition that has no adverse effect on the treated organism The supplement of the invention may comprise excipients such as fructose, water, aromas, dyes, etc.

Preferentemente la composición de la invención está presente en el suplemento de la invención en una cantidad efectiva para proporcionar un efecto antioxidante, así como neuro-, hepato- y nefroprotector en un mamífero, en particular un humano. El vehículo o excipiente debe ser farmacéuticamente tolerable, combinable con la composición de la invención y no presentar efecto adverso alguno sobre el organismo tratado. El suplemento puede presentarse en forma de dosis unitarias. Se prepara según procedimientos bien conocidos en el estado de la técnica del ámbito de la farmacología y/o la alimentación. La cantidad apropiada de composición de la invención comprendida en el suplemento de la invención puede variar en función de la naturaleza del suplemento de forma que en general ésta está comprendida entre el 5 y 95% en peso con respecto al peso total del suplemento.Preferably the composition of the invention is present in the supplement of the invention in an amount effective to provide an antioxidant effect, as well as neuro-, hepato- and nephroprotective in a mammal, in particular a human. He vehicle or excipient must be pharmaceutically tolerable, Combinable with the composition of the invention and having no effect adverse on the treated organism. The supplement can present in the form of unit doses. It is prepared according to procedures well known in the state of the art in the field of pharmacology and / or food. The appropriate amount of composition of the invention included in the supplement of the invention may vary depending on the nature of the supplement of so that in general this is between 5 and 95% by weight with respect to the total weight of the supplement.

El suplemento de la invención puede estar adaptado para su administración oral en forma líquida o sólida. Puede ser entre otros una bebida, o un caramelo, un chicle etc. En una realización particular el suplemento de la invención consiste en una bebida que comprende fructosa como excipiente.The supplement of the invention may be adapted for oral administration in liquid or solid form. It can be among others a drink, or a candy, a gum etc. In a particular embodiment the supplement of the invention consists of a drink comprising fructose as an excipient.

El suplemento puede tener cualquier forma farmacéutica habitual adaptada a su administración oral. Los excipientes en cada caso y su procedimiento de preparación son bien conocidos por un experto en la materia. Entre las formas de administración oral cabe mencionar entre otras grageas, comprimidos opcionalmente recubiertos con película, polvos efervescentes, suspensiones, jarabes, ampollas, etc.The supplement can have any form Regular pharmacist adapted to your oral administration. The excipients in each case and their preparation procedure are well known to a person skilled in the art. Between the ways of oral administration include tablets, tablets optionally film coated, effervescent powders, suspensions, syrups, ampoules, etc.

En una realización particular el suplemento de la invención comprende:In a particular embodiment the supplement of The invention comprises:

50 mg a 4 gr de vitamina C,50 mg to 4 gr of vitamin C,

10 mg a 2 gr de clorhidrato de tiamina;10 mg to 2 gr of thiamine hydrochloride;

       \global\parskip1.000000\baselineskip\ global \ parskip1.000000 \ baselineskip
    

10 mg a 2 gr de clorhidrato de piridoxina;10 mg to 2 gr of pyridoxine hydrochloride;

50 mg a 2,7 gr de N-acetil cisteína;50 mg to 2.7 gr of N-acetyl cysteine;

100 mg a 4 gr de L-asparagina;100 mg to 4 gr of L-asparagine;

10 Ul a 4 gr (2000 Ul) de vitamina E (alfa-tocoferol);10 Ul to 4 gr (2000 Ul) of vitamin E (alpha-tocopherol);

10 mg a 2 gr de ácido L-glutámico;10 mg to 2 gr of L-glutamic acid;

10 mg a 600 mg de cafeína; y10 mg to 600 mg of caffeine; Y

entre 0,00 y 70 gr de fructosa.between 0.00 and 70 gr of fructose

       \vskip1.000000\baselineskip\ vskip1.000000
    

En una realización preferente el suplemento de la invención comprende:In a preferred embodiment the supplement of The invention comprises:

500 mg de vitamina C,500 mg of vitamin C,

300 mg de clorhidrato de tiamina;300 mg of thiamine hydrochloride;

300 mg de clorhidrato de piridoxina;300 mg of pyridoxine hydrochloride;

600 mg de N-acetil cisteína;600 mg of N-acetyl cysteine;

680 mg de L-asparagina;680 mg of L-asparagine;

200 Ul de vitamina E (alfa-tocoferol);200 ul of vitamin E (alpha-tocopherol);

600 mg de ácido L-glutámico;600 mg of acid L-glutamic;

80 mg de cafeína.80 mg of caffeine.

       \vskip1.000000\baselineskip\ vskip1.000000
    

En otra realización más preferente el suplemento presenta, además de estas cantidades indicadas, 25 gr de fructosa.In another more preferred embodiment the supplement it presents, in addition to these indicated quantities, 25 gr of fructose.

En otra realización particular el suplemento de la invención es una composición líquida, preferiblemente en forma de una bebida de típicamente de 200-250 ml.In another particular embodiment the supplement of the invention is a liquid composition, preferably in the form of a drink of typically 200-250 ml.

A continuación se presentan ejemplos ilustrativos de la invención que se exponen para una mejor comprensión de la invención y en ningún caso deben considerarse una limitación del alcance de la misma.Below are examples illustrative of the invention set forth for a better understanding of the invention and in no case should be considered a Limitation of its scope.

       \vskip1.000000\baselineskip\ vskip1.000000
    
Ejemplos Examples Ejemplo 1Example 1

Composición unitaria de 250 ml bebible según la invención que comprende:Unit composition of 250 ml drinkable according to invention comprising:

500 mg de vitamina C,500 mg of vitamin C,

300 mg de clorhidrato de tiamina;300 mg of thiamine hydrochloride;

300 mg de clorhidrato de piridoxina;300 mg of pyridoxine hydrochloride;

600 mg de N-acetil cisteína;600 mg of N-acetyl cysteine;

680 mg de L-asparagina;680 mg of L-asparagine;

200 Ul de vitamina E (\alpha-tocoferol);200 ul of vitamin E (α-tocopherol);

600 mg de ácido L-glutámico;600 mg of acid L-glutamic;

80 mg de cafeína; y80 mg of caffeine; Y

25 gramos de fructosa.25 grams of fructose.

Claims (9)

1. Nueva composición que comprende:1. New composition comprising:
1,82%-59,76% de vitamina C;1.82% -59.76% of vitamin C;
0,34%-40,87% de clorhidrato de tiamina;0.34% -40.87% of thiamine hydrochloride;
0,34%-40,87% de clorhidrato de piridoxina;0.34% -40.87% of pyridoxine hydrochloride;
1,89%-51,00 de N-acetil-L-cisteína;1.89% -51.00 of N-acetyl-L-cysteine;
3,82%-61,41% de L-asparagina;3.82% -61.41% of L-asparagine;
0,21%-30,34% de vitamina E;0.21% -30.34% of Vitamin E;
0,38%-43,54% de ácido L-glutámico; y0.38% -43.54% of L-glutamic acid; Y
0,32%-11,73% de cafeína.0.32% -11.73% of caffeine.
         \vskip1.000000\baselineskip\ vskip1.000000
      
2. Composición según la reivindicación 1, en el que la composición comprende:2. Composition according to claim 1, in the that the composition comprises:
15,65% de vitamina C;15.65% of vitamin C;
9,39% de clorhidrato de tiamina;9.39% of thiamine hydrochloride;
9,39% de clorhidrato de piridoxina;9.39% of pyridoxine hydrochloride;
18,79% de N-acetil-L-cisteína;18.79% of N-acetyl-L-cysteine;
21,29% de L-asparagina;21.29% of L-asparagine;
4,17% de vitamina E;4.17% of Vitamin E;
18,79% de ácido L-glutámico; y18.79% acid L-glutamic; Y
2,50% de cafeína.2.50% of caffeine.
         \vskip1.000000\baselineskip\ vskip1.000000
      
3. Empleo de la composición según una cualquiera de las reivindicaciones 1 o 2, en la elaboración de un suplemento dietético.3. Use of the composition according to any one of claims 1 or 2, in the preparation of a supplement dietary. 4. Suplemento dietético que comprende la composición según una cualquiera de las reivindicaciones 1 o 2, y al menos un excipiente farmacéuticamente aceptable.4. Dietary supplement comprising the composition according to any one of claims 1 or 2, and at less a pharmaceutically acceptable excipient. 5. Suplemento dietético que comprende:5. Dietary supplement comprising:
50 mg a 4 gr de vitamina C,50 mg to 4 gr of vitamin C,
10 mg a 2 gr de clorhidrato de tiamina;10 mg to 2 gr of thiamine hydrochloride;
10 mg a 2 gr de clorhidrato de piridoxina;10 mg to 2 gr of pyridoxine hydrochloride;
50 mg a 2,7 gr de N-acetil cisteína;50 mg to 2.7 gr of N-acetyl cysteine;
100 mg a 4 gr de L-asparagina;100 mg to 4 gr of L-asparagine;
10 Ul a 4 gr (2000 Ul) de vitamina E (alfa-tocoferol);10 Ul to 4 gr (2000 Ul) of vitamin E (alpha-tocopherol);
10 mg a 2 gr de ácido L-glutámico;10 mg to 2 gr of L-glutamic acid;
10 mg a 600 mg de cafeína10 mg to 600 mg of caffeine
y opcionalmente entre 0,00 mg y 70 mg de fructosa.and optionally between 0.00 mg and 70 mg of fructose.
         \vskip1.000000\baselineskip\ vskip1.000000
      
6. Suplemento según la reivindicación 5 que comprende:6. Supplement according to claim 5 that understands:
500 mg de vitamina C,500 mg of vitamin C,
300 mg de clorhidrato de tiamina;300 mg of thiamine hydrochloride;
300 mg de clorhidrato de piridoxina;300 mg of pyridoxine hydrochloride;
600 mg de N-acetil cisteína;600 mg of N-acetyl cysteine;
680 mg de L-asparagina;680 mg of L-asparagine;
200 Ul de vitamina E (alfa-tocoferol);200 ul of vitamin E (alpha-tocopherol);
600 mg de ácido L-glutámico;600 mg of acid L-glutamic;
80 mg de cafeína y opcionalmente 25 mg de fructosa.80 mg of caffeine and optionally 25 mg of fructose.
         \vskip1.000000\baselineskip\ vskip1.000000
      
7. Suplemento según la reivindicación 6 que consiste en 250 ml de composición unitaria bebible.7. Supplement according to claim 6 that It consists of 250 ml of drinkable unit composition. 8. Suplemento según la reivindicación 4 o 5, en forma de una bebida, un caramelo, un chicle o una forma de administración oral líquida o sólida.8. Supplement according to claim 4 or 5, in form of a drink, a candy, a gum or a form of liquid or solid oral administration. 9. Suplemento según la reivindicación 4 o 5 en la que el suplemento se selecciona de entre una gragea, un comprimido, opcionalmente recubierto con película, polvos efervescentes, suspensión, jarabe, y ampolla.9. Supplement according to claim 4 or 5 in which the supplement is selected from among a dragee, a compressed, optionally film coated, powders Effervescent, suspension, syrup, and blister.
ES201031194A 2010-07-30 2010-07-30 ENERGIZING COMPOSITION AND DIETARY SUPPLEMENT CONTAINING IT. Withdrawn - After Issue ES2373901B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201031194A ES2373901B1 (en) 2010-07-30 2010-07-30 ENERGIZING COMPOSITION AND DIETARY SUPPLEMENT CONTAINING IT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201031194A ES2373901B1 (en) 2010-07-30 2010-07-30 ENERGIZING COMPOSITION AND DIETARY SUPPLEMENT CONTAINING IT.

Publications (2)

Publication Number Publication Date
ES2373901A1 true ES2373901A1 (en) 2012-02-10
ES2373901B1 ES2373901B1 (en) 2013-01-08

Family

ID=45509844

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201031194A Withdrawn - After Issue ES2373901B1 (en) 2010-07-30 2010-07-30 ENERGIZING COMPOSITION AND DIETARY SUPPLEMENT CONTAINING IT.

Country Status (1)

Country Link
ES (1) ES2373901B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009000651A1 (en) * 2007-06-22 2008-12-31 Saltigo Gmbh Method of producing 2-phenoxyacetals and the corresponding 2-phenoxy-carbaldehydes therefrom

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009000651A1 (en) * 2007-06-22 2008-12-31 Saltigo Gmbh Method of producing 2-phenoxyacetals and the corresponding 2-phenoxy-carbaldehydes therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A UBERSHOT Energy for life with no lows, enero 2010[recuperado 14-11-2011]. Recuperado de Internet:http://web.archive.org/web/20100124210533/http://ubershot.co.uk/faq.html yhttp://web.archive.org/web/20100125082746/http://ubershot.co.uk/how-ubershot-com.... Documento completo *

Also Published As

Publication number Publication date
ES2373901B1 (en) 2013-01-08

Similar Documents

Publication Publication Date Title
CN101484158B (en) Senescence inhibitor
AU2019200802B2 (en) Synergistic dietary supplement compositions for enhancing physical performance
JP5507802B2 (en) Muscle aging inhibitor
US20150087679A1 (en) Nutritional sleep supplement
US8507015B2 (en) Composition for countering the effects of alcohol consumption
JP4739161B2 (en) Endurance improver
CN118178404A (en) Use of amino acid supplements for increasing muscle protein synthesis
CN101296693B (en) Endurance improver
US10071064B2 (en) Tincture for infusing flavonoids and methods of use
ES2373901A1 (en) Energizing composition and dietetic supplement that contains it. (Machine-translation by Google Translate, not legally binding)
ES2222388T3 (en) COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF METABOLISM DISORDERS OF LIPIDS AND ALLERGIC FORMS.
WO2010107307A1 (en) Kit of parts comprising l-glutamine and egcg
CA2810793C (en) Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
RU2014146562A (en) ALPHA-LIPOIC ACID AND RACNOCIOLE COMPOSITION FOR THE TREATMENT OF NEUROPATHIES
ITRM20000297A1 (en) SUPPLEMENT WITH ANTI-OXIDANT ACTIVITY INCLUDING AN ALCANOYLCARNITINE AND AN ASSOCIATION OF POLYPHENOLS EXTRACTED FROM COCOA.
US20190365707A1 (en) Methods of ameliorating post-dialysis washout and nutritional supplements for use in such methods
US20230364043A1 (en) C5 ketone compositions and related methods for therapeutic and performance supplementation
JP2024117078A (en) Creatine-containing composition
ES2668082B1 (en) COMPOSITION OF DIETETIC COMPLEMENT
TW202233202A (en) Crystalline lens stiffness regulating agent
Energy Why Stimulants Aren’t The Answer
HK1086725A1 (en) Antioxidative compositions
HK1086725B (en) Antioxidative compositions
TH126123A (en) Constituents to relieve symptoms of low blood albumin
GB2454095A (en) Micro-nutrient preparation in particular for migraine prophylaxis

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2373901

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20130108

FA2A Application withdrawn

Effective date: 20130506